Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
93.09
+0.04 (0.04%)
Jun 27, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Anti-tumor
1.98B
Log In
Log In
Log In
Log In
Upgrade
Anti-tumor Growth
150.22%
Log In
Log In
Log In
Log In
Upgrade
Technical Licensing
40.61M
Log In
Log In
Log In
Log In
Upgrade
Technical Licensing Growth
6442.52%
Log In
Log In
Log In
Log In
Upgrade
Other Business
63.91K
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
9.71%
Log In
Log In
Log In
Log In
Upgrade
Lansoprazole Enteric Capsules
-
Log In
Log In
Log In
Log In
Upgrade
Lansoprazole Enteric Capsules Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
China
1.98B
Log In
Log In
Log In
Log In
Upgrade
China Growth
150.68%
Log In
Log In
Log In
Log In
Upgrade
Overseas
35.41M
Log In
Log In
Log In
Log In
Upgrade